| P2093 | author name string | Scott Davis | |
| | Dana K Mirick | |
| P2860 | cites work | Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 |
| | Risk of breast cancer among users of aspirin and other anti-inflammatory drugs | Q28169157 |
| | Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer | Q28194496 |
| | Association of regular aspirin use and breast cancer risk | Q28211831 |
| | Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | Q28213690 |
| | A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women | Q33197092 |
| | Night shift work, light at night, and risk of breast cancer | Q34095441 |
| | Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer | Q35091167 |
| | The effects of tricyclic antidepressants on breast cancer risk | Q37352645 |
| | Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast | Q40534891 |
| | Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women | Q43753449 |
| | Residential magnetic fields and the risk of breast cancer | Q43897945 |
| | Antidepressant medication use and breast cancer risk: a case-control study | Q44697398 |
| | Psychotropic medication use and risk of hormone-related cancers: the New York University Women's Health Study | Q44817083 |
| | Use of calcium channel blockers and breast carcinoma risk in postmenopausal women | Q45154192 |
| | Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses | Q45176275 |
| | Breast cancer risk in a large cohort of female antidepressant medication users | Q46219701 |
| | Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65–79 years | Q47606588 |
| | Cancer risk in users of calcium channel blockers. | Q50956016 |
| | Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa. | Q54271753 |
| | Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer | Q57945086 |
| | Calcium-channel blockers and risk of cancer | Q57945355 |
| | Risk of Breast Cancer According to Use of Antidepressants, Phenothizaines, and Anthistamines | Q59764309 |
| | Calcium Channel Blockers and the Risk of Cancer | Q59764355 |
| | The effect of a serotonin uptake inhibitor (Lilly 110140) on the secretion of prolactin in the rat | Q66880133 |
| | Calcium-channel blockade and incidence of cancer in aged populations | Q71396282 |
| | Calcium channel blockers and cancer: is an association biologically plausible? | Q71531461 |
| | Antidepressant medication use and breast cancer risk | Q73895490 |
| | Cancer risk and mortality in users of calcium channel blockers. A cohort study | Q74008896 |
| | Antidepressant use and the risk of breast cancer: a non-association | Q74139082 |
| | Cancer risk of hypertensive patients taking calcium antagonists | Q74418629 |
| | Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study | Q77526196 |
| P433 | issue | 5 | |
| P304 | page(s) | 319-325 | |
| P577 | publication date | 2007-05-09 | |
| P1433 | published in | European Journal of Epidemiology | Q5412723 |
| P1476 | title | Medication use and the risk of breast cancer | |
| P478 | volume | 22 | |